Explore our core medical supplies engineered with advanced bio-compatible materials and precise manufacturing protocols.
Founded with a strong commitment to the healthcare industry, Hebei ROA Medicare Co., Ltd. has been dedicated to providing high-quality medical and healthcare products to customers worldwide. Over the years, we have consistently upheld the belief that “Health, Trust, and Innovation are the foundation of every family and society.”
Driven by this philosophy, ROA Medicare has grown into a professional and reliable supplier in the global healthcare market, continuously improving product quality, expanding international cooperation, and contributing to better healthcare solutions for people around the world. As a premier provider among Infusion Systems Manufacturers & Suppliers, we combine state-of-the-art engineering with rigorous bio-compatibility compliance to safeguard patient outcomes across critical care settings.
The name “ROA Medicare” represents responsibility, professionalism, and care for human health. We believe that healthcare is not only about products, but also about trust, safety, and long-term commitment to customers and patients worldwide. Our company logo and brand identity reflect our dedication to the medical industry. The combination of blue and green symbolizes professionalism, reliability, health, and vitality. Blue represents safety, precision, and trustworthiness, while green reflects life, healing, sustainability, and hope. Together, they embody our mission to deliver safe and effective medical products that improve quality of life.
At ROA Medicare, we understand that every product we manufacture and every service we provide can directly impact human health and well-being. Therefore, we always adhere to our core philosophy: “Health First, Quality Foremost, Trust Always.”
We maintain stringent quality control standards across raw material selection, automated molding, line assembly, and double-barrier sterile packaging to guarantee absolute compliance.
We invest heavily in R&D for advanced drug-delivery accuracy, anti-bolus pressure monitoring, microfluidic chips, and smart telemetry integration for modern EHR networks.
We provide long-term OEM/ODM manufacturing stability, OEM customized branding, transparent regulatory documentation, and agile localized technical assistance worldwide.
The global infusion systems market is undergoing a profound paradigm shift driven by an aging global demographic, escalating prevalence of chronic conditions requiring prolonged intravenous therapies (such as oncology, clinical nutrition, and chronic pain management), and the accelerated migration toward decentralized ambulatory care settings. Modern clinical environments no longer evaluate infusion pumps and consumables as standalone instruments; rather, they are scrutinized as critical components of an integrated, data-driven medical ecosystem.
Regulatory mandates across North America and Europe, including the transition to EU MDR (2017/745) and stringent US FDA 510(k) cyber-device guidance, have elevated the baseline requirements for infusion technology manufacturers. Equipment must demonstrate not only bio-compatibility and physical durability, but also advanced software resiliency, precise anti-free-flow protection, volumetric accuracy within tight tolerances (±2% to ±5%), and seamless interface capabilities with hospital Information Systems (HIS) and Electronic Health Records (EHR) via ISO 80369 standardized connectors.
Modern clinical guidelines demand multi-channel peristaltic and syringe pumps capable of delivering sub-milliliter precision (down to 0.01 mL/h), equipped with real-time ultrasonic bubble detection and dual-sensor pressure monitoring to prevent vascular complications and accidental bolus administration.
There is a global industry transition toward DEHP-free, PVC-free, and light-protected polyurethane infusion tubing. This mitigates drug absorption risks during oncology protocol infusions and eliminates toxic plasticizer leaching into patient bloodstreams.
With wireless-enabled smart pumps integrated into Dose Error Reduction Systems (DERS), securing bi-directional HL7/FHIR communication protocols against unauthorized network breaches has become a foundational requirement for modern hospital procurement.
Optimizing patient care from high-acuity intensive care units to remote field operations and home-based infusion therapies.
In high-acuity ICU environments, patients frequently require simultaneous administration of multiple vasoactive drugs, sedatives, and concentrated electrolytes. ROA Medicare's infusion systems offer multi-channel synchronization, ultra-low micro-infusion rates, and rapid response occlusion sensors to maintain hemodynamic stability without risk of pressure spikes.
The global trend toward decentralized care demands ambulatory infusion pumps that are lightweight, battery-efficient, and user-friendly for non-professional caregivers. Our systems incorporate intuitive color-coded touch interfaces, anti-tamper locking mechanisms, and silent operational profiles to maximize patient comfort during prolonged home-based chemotherapy or antibiotic regimens.
Neonatal patients exhibit extreme sensitivity to fluid volume variations. ROA Medicare delivers specialized micro-dosing syringe systems capable of maintaining exact flow precision down to micro-liter increments, supported by light-resistant fluid pathways designed specifically to protect sensitive intravenous nutrition mixtures from photodegradation.
For disaster relief, military field medical units, and mobile emergency setups, infusion hardware must withstand extreme environmental vibrations, temperature fluctuations, and rugged handling. Coupled with our mobile microwave steam sterilization systems, ROA Medicare provides deployable solution sets engineered for field operation reliability.
Targeting the convergence of Artificial Intelligence, microfluidics, and cloud-connected patient monitoring.
Integrating machine learning algorithms with continuous physiological sensors to automatically adjust infusion flow rates for propofol, insulin, or vasopressors, maintaining optimal therapeutic windows while reducing caregiver workload.
Transitioning from traditional mechanical peristalsis to solid-state microfluidic MEMS pumps. This technology enables micro-scale portability, virtually silent operation, and maintenance-free device lifecycles.
Deploying cloud-connected diagnostic software that monitors pump motor health, battery cycles, and sensor calibration status in real-time, allowing biomedical engineering teams to perform preventive maintenance prior to clinical failure.
Hebei ROA Medicare Co., Ltd. operates an expansive, vertically integrated manufacturing matrix in Hebei Province, China. By controlling every stage of production—from raw polymer synthesis and precision injection molding to automated assembly, water purification, liquid compounding, filling, and final ethylene oxide (EO) or gamma sterilization—we ensure unmatched batch-to-batch consistency and rapid scalability.
Our strategic placement within China's medical industrial cluster grants direct access to robust raw material supply chains, reducing lead times for high-volume hospital orders. Operating under strict ISO 13485 quality control protocols within ISO Class 8 (100,000-grade) cleanrooms, our automated manufacturing infrastructure minimizes human touch intervention, virtually eliminating contamination risks while maintaining optimal cost efficiency for our international distributors and hospital clients.
Navigating global healthcare regulations requires more than just manufacturing capability; it demands localized regulatory dossier preparation, post-market surveillance (PMS), and comprehensive technical assistance. ROA Medicare supports OEM partners, hospital authorities, and regional medical distributors with end-to-end documentation packages tailored to local Ministry of Health requirements.
Fully compliant with EU Regulation 2017/745, backed by extensive clinical evaluation reports (CER) and risk management documentation under ISO 14971.
Dossiers prepared in alignment with US FDA requirements, including human factors engineering (HE75) and cyber-device risk assessments.
Comprehensive Quality Management System governing production, cleanroom environmental monitoring, design control, and corrective action workflows.
Dedicated technical teams providing rapid biomedical engineer training, spare parts dispatch, regulatory renewal filings, and field safety notice support.
Addressing technical, operational, and regulatory queries from clinical procurement teams and hospital biomedical engineers.
Explore our expanded array of surgical sutures, drapes, specialized sampling devices, and sterilizing field units.
Facing the future, Hebei ROA Medicare Co., Ltd. will continue to strengthen international cooperation, expand global markets, and enhance innovation capabilities. We are committed to becoming a trusted global healthcare partner by delivering professional products, reliable quality, and exceptional service. Together with our customers and partners, we look forward to creating a healthier, safer, and better future for people around the world.
ROA Medicare
